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Shinichiro tsunoda, 23 Jun Shimizu, 24 Keishi Fujio, 18 Hirofumi Amano, 25 Akio Mimori, 26 Atsushi Kawakami, 27 Hisanori Umehara, 28 tsutomu takeuchi, 29 Hajime Sano, 23 Yoshinao Muro, 21 tatsuya Atsumi, 20 toshihide Mimura, 19 Yasushi Kawaguchi, 17 tsuneyo Mimori, 5 Atsushi takahashi, 2 Michiaki Kubo, 6 Hitoshi Kohsaka, 22 takayuki Sumida, 3 Kazuhiko Yamamoto 1, 18 ABstrAct Objectives Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare autoimmune diseases in which both genetic and environmental factors play important roles. to identify genetic factors of IIM including polymyositis, dermatomyositis (dM) and clinically amyopathic dM (CAdM), we performed the first genome-wide association study for IIM in an Asian population. Methods We genotyped and tested 496 819 single nucleotide polymorphism for association using 576 patients with IIM and 6270 control subjects. We also examined the causal mechanism of disease-associated variants by in silico analyses using publicly available data sets as well as by in in vitro analyses using reporter assays and apoptosis assays. results We identified a variant in WDFY4 that was significantly associated with CAdM (rs7919656; or=3.87; p=1.5×10 −8 ). this variant had a cis-splicing quantitative trait locus (QtL) effect for a truncated WDFY4isoform (tr-WDFY4), with higher expression in the risk allele. transexpression QtL analysis of this variant showed a positive correlation with the expression of nF-κB associated genes. Furthermore, we demonstrated that both WdFY4 and tr-WdFY4 interacted with pattern recognition receptors such as tLr3, tLr4, tLr9 and MdA5 and augmented the nF-κB activation by these receptors. WdFY4 isoforms also enhanced MdA5-induced apoptosis to a greater extent in the tr-WdFY4-transfected cells. conclusions As CAdM is characterised by the appearance of anti-MdA5 autoantibodies and severe lung inflammation, the WdFY4 variant may play a critical role in the pathogenesis of CAdM.
IntrOductIOn
Idiopathic inflammatory myopathies (IIMs) are autoimmune conditions characterised by muscle weakness and inflammation, and the most common types are polymyositis (PM) and dermatomyositis (DM). 1 2 Clinically amyopathic DM (CADM), a subset of DM, lacks distinct muscle features but often manifests rapidly progressive interstitial pneumonia (RPIP). [3] [4] [5] [6] The mortality rate of CADM at 6 months from diagnosis reaches approximately 50%, making it one of the most fatal autoimmune diseases. 7 8 The appearance of autoantibodies such as anti-MDA5 antibodies in CADM suggests a role for autoimmunity in the pathogenesis. [9] [10] [11] Although the aetiology of IIM remains unknown, virus infection may be the major environmental factor. 12 In addition, patients with IIM and their close relatives are more likely to develop other autoimmune diseases, suggesting shared genetic factors. [13] [14] [15] In fact, a previous genome-wide association studies (GWAS) and candidate gene analyses in European populations demonstrated multiple loci that were shared with other autoimmune diseases. [15] [16] [17] [18] However, when compared with other autoimmune diseases, little is known about the genetic background of IIM. This may be due to the rarity of disease, precluding researchers from designing sufficiently powered studies. In addition, because IIMs are a heterogenous group of rare disorders, an overall pooled analysis might also reduce the power for detecting loci specific to certain subtypes. Therefore, as suggested, 19 studies of disease subsets are needed to increase the power for detecting subset-specific genetic components. Here, to elucidate genetic loci associated with IIM, we performed a GWAS for IIM in the Japanese population. This study was the first GWAS for IIM in an Asian population. We also performed a GWAS for CADM as a subset analysis, which was the first such study in the world. 
MethOds subjects

Basic and translational research
in Japan. PM/DM fulfilled the definite or probable diagnostic criteria of Bohan and Peter. 1 The diagnosis of CADM was based on the criteria by Sontheimer et al. 3 6 We enrolled 6270 control subjects without history of autoimmune diseases (mean age, 57.0±13.8 years; female, 48.2%) through the Biobank project. 20 The European subjects (21 CADM cases) were recruited as part of an international myositis genetics consortium (MYOGEN), 17 and four controls for each case (84 controls) were matched for ethnicity using principal components analysis (PCA) coordinates.
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Genome-wide association studies
We genotyped case samples using HumanOmniExpressExome BeadChip and control samples using HumanOmniExpress BeadChip and HumanExome BeadChip (Illumina). For quality control, we excluded single nucleotide polymorphisms (SNPs) with a call rate <0.99, a mean allele frequency (MAF) <0.05 and those not in Hardy-Weinberg equilibrium in controls (P<1×10 −6 ). We removed samples that showed second-degree relatedness or closer by an identity-by-state method. We performed PCA using four reference populations from HapMap data including CEU, YRI, JPT and CHB using SmartPCA software. 22 We identified outliers not belonging to the JPT/CHB cluster by using the top two principal components. After this screening, we selected 576 cases and 6270 controls for subsequent analysis. This sample size had statistical power >0.5 for detecting common variants with moderate effects (MAF=0.5 and OR=1.5) as calculated by QUANTO. 23 The European samples were genotyped by the Immunochip (Illumina). 18 We performed genotype imputation within the WDFY4 locus by Minimac 24 using the 1000 Genomes Project Asian data as reference.
expression quantitative trait locus (eQtL) analysis
Both cis-eQTL and trans-eQTL analyses were performed using Matrix eQTL with the linear model. 25 We used the Geuvadis project data 26 of European samples (n=373), ' GD462. GeneQuantRPKM. 50FN. samplename. resk10. norm. txt' for the gene level eQTL analysis and ' GD462. ExonQuantCount. 45N. 50FN. samplename. resk10. txt' for the exon level eQTL analysis.
Weighted parametric gene set analysis (wPGsA)
To predict the activities of transcriptional regulators responsible for observed gene expression changes resulting from trans-eQTL effects of tr-WDFY4, we used wPGSA 27 with some modifications (online supplementary figure S7 ). ChIP-seq data of multiple types of human cells were obtained from the GEO database. In total, 3082 ChIP-seq data of 431 transcriptional factor (TFs) were used. We used the trans-eQTL effects of WDFY4 variant (rs7919656) on every gene (β obtained by Matrix eQTL) as input, instead of the log-fold change of the gene expression.
reporter assay
The coding sequences of WDFY4 and tr-WDFY4 were cloned into the pcDNA3.1D/V5-His-TOPO vector using cDNAs from Epstein-Barr virus (EBV)-immortalised B cells. Human pattern recognition receptors (PRRs) were cloned into the pEF-BOS-FLAG vector (TLR3 was provided by Dr Matsumoto, Hokkaido University; TLR4 and TLR9 were provided by Dr Miyake, University of Tokyo). UNC93B1 was cloned into the pcDNA5/FRT/ V5-His vector. UNC93B1 was cotransfected for the experiments of TLR7 or TLR9, because it is essential to deliver these receptors to endolysosomes. 28 We cultured HEK-293 cells in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum. We transfected WDFY4 expression vectors, the pGL4.32 vector (nuclear factor-kappa B (NF-κB) response element and luc2P) and the pGL4.74 vector (hRluc/TK) (Promega) into cells using the X-tremeGENE HP Transfection Reagent (Roche). The p55C1B-Luc vector 29 (provided by Dr Fujita, Kyoto University) was used instead of pGL4.32 for IRF3 reporter assays. After 18 hours incubation, the cells were stimulated with poly (I:C) (Enzo Life Sciences), LPS (Sigma-Aldrich), imiquimod (InvivoGen), ODN2006 (InvivoGen) or high molecular weight poly (I:C) 30 (provided by Dr Fujita) for 4 hours. We then collected the cells and measured luciferase activity using Dual-Luciferase Reporter Assays according to the manufacturer's protocol (Promega).
Immunoprecipitation and western blotting
HEK-293 cells were transfected with each WDFY4 isoform and PRR and cultured for 24 hours. The cells were lysed in radioimmunoprecipitation (RIPA) buffer 31 and then incubated with Dynabeads protein-G (Life Technologies) coated with anti-FLAG-antibody (Sigma-Aldrich) and incubated at 4°C for 30 min. The beads were then washed and boiled in sodium dodecyl sulfate (SDS) buffer before electrophoresis through NuPAGE Tris-Acetate gels. The proteins were transferred to polyvinylidene fluoride (PDVF) membranes (Millipore), which were then probed with anti-V5 antibody (Invitrogen), visualised using ECL reagent (GE Healthcare) and detected using LAS-3000 (Fujifilm). We also performed immunoprecipitation using the sera from patients, instead of anti-FLAG-antibody.
Apoptosis assay
HepG2 Cells were transfected with each WDFY4 isoform using the Lipofectamine 3000 reagent (Invitrogen). The same vector with cloned LacZ was also transfected as a mock. Cells were incubated for 24 hours and stimulated with 5 µg of poly (I:C). The cells were permeabilised and stained with CaspACE FITC-VAD-FMK (Promega) and anti-His-Alexa 647. Caspase activity was evaluated in the His-positive cells using the BD Accuri C6 flow cytometer (BD Biosciences) to detect apoptotic cells. 
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Immunofluorescence staining HEK-293 cells were grown on coverslips and transfected with the vectors for WDFY4 isoforms and MDA5. Cells were fixed in 4% paraformaldehyde, permeabilised in 0.25% Triton X-100 and stained with anti-V5 and antimouse IgG Alexa488
(Invitrogen) for WDFY4 and anti-FLAG-Cy3 (Sigma-Aldrich) for MDA5 detection. DAPI was used for counterstaining. Images were acquired with the confocal microscope N-SIM (Nikon) using 100× objective lens. The data were analysed in 3D-SIM mode by using NIS-Elements software (Nikon). Each PRR was immunoprecipitated with anti-FLAG Ab. Coimmunoprecipitated WDFY4 isoforms were then detected by western blotting (WB) using anti-V5 Ab. Each experiment was repeated twice, and the representative data were shown. NF-κB, nuclear factor-kappa B.
Basic and translational research Measurement of anti-MdA5
We measured anti-MDA5 autoantibodies in the sera from the patients with CADM (18 sera were available) by protein-immunoprecipitation.
statistics
We tested the association of SNPs by allelic test using Plink 1.9, 32 setting the genome-wide significance threshold at α=5×10 −8 . We used a quantile-quantile plot to evaluate the potential effects of population stratification. We used analysis of variance with post hoc Tukey's test in the reporter assays and apoptosis assays.
resuLts
GWAs for IIM
We genotyped the Japanese samples using Illumina SNP arrays for over 960 000 SNPs. After quality control filtering, the effective sample size was 576 IIM cases and 6270 controls, and 496 819 SNPs were tested. The 
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genomic inflation factorλ GC was 1.024 (online supplementary figure S1), suggesting a negligible effect of population stratification. Cases comprised 236 patients with PM and 340 patients with DM including 33 patients with CADM, and GWASs for these disease subsets were also performed. No significant association signal (P<5×10 −8 ) was found in any of total IIM, PM or DM (online supplementary figure  S2 ). However, when CADM patients were evaluated alone, a significant association was observed for an intronic SNP of WDFY4 (WDFY Family Member 4; rs7919656; OR=3.87; 95% CI 2.23 to 6.55; P=1.5×10 −8 ) ( figure 1A and table 1 ). This SNP showed a nominal association with IIM, even when patients with CADM were excluded (P=0.037). In European patients with CADM, although no obvious association signal was observed in rs7919656, distinct association signals (r 2 <0.2 with rs7919656) were observed for the neighbouring variants (rs11101462, P=0.0092; rs2889697, P=0.0058, online supplementary figure S3 ). Immunoprecipitation (IP) analysis using sera from patients with CADM. MDA5 and tr-WDFY4 were cotransfected into HEK-293 cells, and the cell lysates were immunoprecipitated with sera from patients with CADM (three anti-MDA5-positive patients and an anti-MDA5-negative patient. For comparison with another subset of myositis, sera from an anti-aminoacyl tRNA synthetase (ARS) positive DM patient as well as a healthy control (HC) were evaluated. Immunoprecipitated MDA5 proteins were detected by western blotting (WB) with anti-FLAG Ab (upper panel), and coimmunoprecipitated tr-WDFY4 proteins were detected with anti-His Ab (lower panel). CADM, clinically amyopathic dermatomyositis.
splicing QtL effect of WdFY4 variant on truncated isoform
To unravel the causal mechanism of the WDFY4 locus in this disease subset, we first searched for candidate functional variants. Among the variants in strong linkage disequilibrium (LD) with rs7919656 (r 2 >0.8) in the 1000 genome project Asian samples, there is no coding variant that altered the amino acid sequences of neighbouring genes (online supplementary figure  S4 ). We next searched the eQTL data of lymphoblastoid B cells provided by the Geuvadis project. 26 When correlations of the SNP (rs7919656) genotype and expression of both the gene and exons were evaluated, a significant eQTL effect for an alternative exon of WDFY4 was found (figure 1B). As no obvious eQTL effect was observed for expression of the whole gene or of neighbouring exons (online supplementary figure S5) , this variant or variants in LD may have a splicing QTL effect for this WDFY4 isoform. Among such variants, two SNPs in intron 35 (rs10776647/rs10776648; figure 1C and online supplementary figure S4 ) were candidate causal variants in this region; however, they did not disrupt classical splicing associated motifs. The alternative exon extends exon 36 of WDFY4, which introduces an alternate stop codon and truncates the protein ( figure 1C,D) . We verified the existence of this truncated isoform (tr-WDFY4) by cloning it with cDNA from EBV-immortalised B cells and expressing it in HEK-293 cells ( figure 1E ).
trans-eQtL effect of WdFY4 variant on nF-κB activity
WDFY4 encodes WDFY family member 4, which has a predicted BEACH domain and five WD domains at the C-terminal side 33 ( figure 1D ). Although WDFY4 is expressed in dendritic cells, neutrophils, B cells and macrophages (online supplementary figure S6 ), to our knowledge, there have been no studies into its protein function. To obtain insight regarding the function of WDFY4, we performed trans-eQTL analysis of the variant using the same expression data of lymphoblastoid B cells. A total of 387 genes were correlated with the number of risk alleles (uncorrected P<0.05), although no gene displayed genomewide significant correlation (FDR<0.05). Notably, 279 genes (72.1%) were positively correlated, indicating that upregulated expression of tr-WDFY4 results in upregulation of these genes. Among the top 10 genes with the largest trans-eQTL effects (β as calculated in the Matrix eQTL analysis), TYK2 and PTPN6 are well-known regulators of signal pathways in B cells ( figure 2A) . We then sought to identify the TFs present downstream of tr-WDFY4 by wPGSA. 27 wPGSA uses all available ChIP-seq data obtained from multiple types of human cells and predicts the activities of transcriptional regulators responsible for observed gene expression changes ( figure 2B and online supplementary  figure S7 ). When trans-eQTL effects (β) were used as input, among the 431 TFs evaluated, 6 TFs displayed significant associations (FDR<0.05) (figure 2C and online supplementary table S1). We focused on TF65 (RELA/p65), because it comprises NF-κB heterodimers that are one of the most important TFs in the immune system. 34 Based on these findings, we assumed that the NF-κB pathway is activated downstream of WDFY4. Indeed, NF-κB reporter assays showed that both WDFY4 and tr-WDFY4 enhanced NF-κB activity when transfected into HEK-293 cells with stimulation of tumour necrosis factor alpha ( figure 2D ).
WdFY4 augments signals of innate Prrs
These observations, as well as a recent report that WDFY1, another member of the WDFY gene family, augmented TLR3 and TLR9 signalling, 35 motivated us to investigate the role of WDFY4 in PRR signalling. We chose TLR3/TLR4/TLR7/TLR9 and MDA5 for analysis considering their implied roles in disease pathogenesis, 4 36 37 as well as their potential to activate NF-κB. 38 We first performed NF-κB reporter assays by simultaneously transfecting each WDFY4 isoform with each PRR. While both WDFY4 isoforms enhanced NF-κB signalling of TLR3/TLR4/ TLR9 and MDA5, they had a negligible effect on TLR7 signalling ( figure 3A) . Of note, tr-WDFY4 markedly enhanced the MDA5 signal when stimulated with poly (I:C), a synthetic analogue of double-stranded RNA. We also examined the impact of WDFY4 isoforms on cytokine production by quantifying the levels of interleukin (IL)-8 in the cell culture supernatants. Although both isoforms significantly increased the IL-8 production in steady state, the difference to mock transfectant became insignificant when cells were stimulated with poly (I:C) (online supplementary figure S8 ). Next, we examined the physical interaction of WDFY4 isoforms and these PRRs by coimmunoprecipitation. Both V5-tagged WDFY4 isoforms interacted with these FLAGtagged PRRs to greater or lesser degrees ( figure 3B ). The strongest interaction was observed between tr-WDFY4 and MDA5, which was consistent with the findings of reporter assays. MDA5-mediated sensing of virus triggers endogenous immune responses and cellular apoptosis to eliminate virus-infected cells. 39 Therefore, to further evaluate the function of WDFY4 in the context of MDA5 signalling, we performed apoptosis assays. We used HepG2 cells for these assays, because stimulation of these cells with poly (I:C) is accompanied by upregulation of MDA5 and results in the induction of apoptosis 40 ( figure 4A ). When HepG2 cells were transfected with the WDFY4 isoforms and stimulated with/without poly (I:C), apoptosis was augmented to a greater extent in the tr-WDFY4-transfected cells than in the WDFY4-transfected cells ( figure 4B ). Again, this result is consistent with the observations regarding these isoforms in the NF-κB assays. As the apoptosis induced by MDA5 was reported to be independent of type I interferon signals, 41 we evaluated the effect of WDFY4 isoforms on type I interferon induction by cotransfected MDA5 using IRF3 reporter assays. 29 For comparison, we also examined TLR3 signalling. While no effect of WDFY4 isoforms on TLR3 induction of interferon was detected, MDA5 induction of interferon was markedly repressed when the WDFY4 isoforms were cotransfected with MDA5 ( figure 4C ). These findings suggested that the WDFY4 isoforms are able to interact with MDA5 and alter its signalling in cells. This possibility was further supported by the observations that transfected WDFY4 isoforms and MDA5 co-localised in the cytoplasm of cells as assessed using immunofluorescence ( figure 5A ) and that the anti-MDA5-positive sera from patients could coimmunoprecipitate tr-WDFY4 proteins ( figure 5B ).
dIscussIOn
Here we demonstrated a significant association between a variant in WDFY4 and CADM susceptibility. Association of WDFY4 locus has been previously reported with systemic lupus erythematosus (SLE) 42 and rheumatoid arthritis. 43 A recent study reported that the SLE risk variant (rs2663052) also had a splicing QTL effect on WDFY4. 44 However, rs2663052 is not in tight LD with the CADM risk variant (rs7919656, r 2 =0.46 in the Asian samples), and rs2663052 displayed a weaker association signal in CADM in the present study (P=0.0012). A missense variant (rs7097397), which is in moderate LD with rs7919656 (r 2 =0.58 in the Asian samples), may be another candidate causal variant in SLE, 42 but the association in CADM was moderate (P=0.0022). The fact that the CADM risk variant was also associated with upregulated expression of tr-WDFY4 suggested that WDFY4 was Basic and translational research a strong candidate gene in this locus. Although the biological function of WDFY4 was unknown, our analysis by wPGSA using the trans-eQTL effects of WDFY4 variant implied that NF-κB was involved in the downstream regulation of WDFY4. Indeed, as demonstrated by in vitro assays, tr-WDFY4 augmented the NF-κB signals induced by PRRs including MDA5. Our in vitro assays also demonstrated that the intact WDFY4 augmented MDA5-induced NF-κB signal and apoptosis but to lesser extent than tr-WDFY4. The differences in function between the intact WDFY4 and tr-WDFY4 should be further examined, but the lack of predicted WDFY4 protein domains (BEACH and WD domains) may have a marked impact on tr-WDFY4 function. Moreover, the suppression of IRF3 activity observed in the reporter assays suggests the role of WDFY4 in interferon signalling pathway. Because WDFY4 was shown to be downregulated in patients with SLE, 45 WDFY4 isoforms may control the balance between interferon and NF-κB pathways, which should be further examined.
The lack of an association for rs7919656 (sQTL variant) in the European patients might be due to a lack of statistical power, because it diminished to 0.32 if a moderate effect size (OR=1.5) was assumed. However, as rs11101462, which displayed a positive association signal in Europeans, had an eQTL effect for WDFY4 in peripheral blood samples with higher expression in the risk allele (online supplementary table S2), WDFY4 may also have a role in CADM in Europeans. The genetic heterogeneity observed between these populations might be partially explained by environmental factors. Because the extent of MDA5 signal transduction depends on the characteristic of ligands (viruses) such as their length, 30 the effects of WDFY4 isoforms on the MDA5 signalling pathway may also depend on the ligands. Therefore, if viruses trigger the disease and the type of viruses is different between the populations, the genetic role of the two variants and their related WDFY4 isoforms may also differ. The higher incidence of RPIP reported in Asian populations 4 46 may indeed suggest aetiological heterogeneity in CADM.
An autoimmune reaction to MDA5 may be a central event in CADM pathogenesis, because CADM is characterised by the appearance of anti-MDA5-Abs. This phenomenon was also observed in 72.2% (n=13/18) of the patients with CADM evaluated, and these anti-MDA5-positive sera from patients could coimmunoprecipitate tr-WDFY4 proteins. Interestingly, the serum from an anti-MDA5-negative patient could coimmunoprecipitiate tr-WDFY4 proteins, which might suggest the presence of anti-WDFY4 antibody. An inflammatory condition following exposure to antigens derived from apoptotic cells is one of the main mechanisms that trigger autoimmune disorders as shown in the animal models. 47 Therefore, our findings that tr-WDFY4 enhanced both inflammatory signals and apoptosis induced by MDA5 suggest that tr-WDFY4 has a critical role in the autoimmune response to MDA5 and possibly to WDFY4.
Moreover, because tr-WDFY4 augmented the NF-κB signals induced by PRRs, tr-WDFY4 may be also involved in the pathogenesis of RPIP. However, the high mortality rate of RPIP might have precluded the CADM patients with RPIP from participating in the study. Therefore, our samples might have underestimated the role of WDFY4 variant in this disease subset, particularly in patients with RPIP. To determine whether the WDFY4 variant can be used as a predictive biomarker for RPIP, a prospective study of patients with new-onset CADM (or anti-MDA5-positive patients) is needed. Meanwhile, by assessing the environmental exposure, viral infections in particular, the role of gene-environmental interactions can be examined. As RPIP in CADM is still refractory to intense immunosuppressive therapies, tr-WDFY4 would be a candidate target in the treatment of CADM . 
